A resolution designating September 2023 as "National Cholesterol Education Month" and September 30, 2023, as LDL-C Awareness Day.
Legislative Progress
Introduced
December 13, 2023
Latest Action
February 27, 2024
Primary Sponsor
Cindy Hyde-SmithRepublican(MS)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
98pct
76d open
vs 942 other SRES bills in the 118th — cohort avg 6d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · second_quarter · Health Issues
Access to AEDs Act (H.R. 2370/S. 1024) Cardiac Arrest Survival Act (H.R. 1012) Easy Enrollment in Healthcare Act (H.R. 1113/S. 423) Palliative Care and Hospice Education and Training Act (S.2243) Self-Insurance Protection Act (H.R. 2813) Telehealth Benefit Expansion for Workers Act (H.R. 824) Association Health Plans Act (H.R. 2868) Improving Whole Health for Veterans with Chronic Conditions Act (S. 1954) FAMILY Act (S. 1714/H.R. 3481) Social Determinants of Health Act of 2023 (no bill number) Preventing Maternal Deaths Reauthorization Act of 2023 (H.R. 3838/S. 2415) PREEMIE Reauthorization Act of 2023 (H.R. 3226/S. 1573) Charles Rochester Blood Clot Prevention and Treatment Act (H.R. 5699) Cardiomyopathy Health Education, Awareness, Research, and Training in the Schools (HEARTS) Act (HR 6829) Alleviating Barriers to Caregiving (ABC) Act (S. 3109) Legislation to enhance research, data collection, and education about stroke (no bill number) Harold B. Kohl Physical Activity for Americans Act (no bill number) Congenital Heart Futures Reauthorization Act of 2024 (H.R.7189) A resolution designating September 2023 as "National Cholesterol Education Month" and September 30, 2023, as LDL-C Awareness Day (S.Res.496) A resolution designating September 2024 as "National Cholesterol Education Month" and September 30, 2024, as "LDL-C Awareness Day" (S.Res.566) Expressing support for the goals and ideals of National Stroke Awareness Month (H. Res. 1216) A resolution designating May 2024 as American Stroke Month (S. Res. 711) Implementation of the No Surprises Act Department of Labor action to rescind Association Health Plan Final Rule (RIN 1210-AC16) HHS finalization of proposed rule on Section 1557; Nondiscrimination in Health Programs and Activities (RIN Number 0945AA17) HHS finalization of proposed rule on Clarifying Eligibility for a Qualified Health Plan (CMS-9894-P) HHS finalization of proposed rule on Short-Term, Limited-Duration Insurance; Independent, Non- coordinated Excepted Benefits Coverage; Level-Funded Plan Arrangements; and Tax Treatment of Certain Accident and Health Insurance (CMS-9904-P)
Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. (consideration: CR S1014; text: 12/13/2023 CR S5964)
Passed/agreed to in Senate: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. (consideration: CR S1014; text: 12/13/2023 CR S5964)
Senate Committee on the Judiciary discharged by Unanimous Consent.
Senate Committee on the Judiciary discharged by Unanimous Consent.
Referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $670,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
2024 · first_quarter · Health Issues
Cardiovasular disease issues; S.Res. 496 - A resolution designating September 2023 as "National Cholesterol Education Month" and September 30, 2023, as LDL-C Awareness Day; S.Res. 566, a resolution designating September 2024 as "National Cholesterol Education Month" and September 30, 2024, as "LDL-C Awareness Day."
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Pharmacy
Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including S. 127, Pharmacy Benefit Manager Transparency Act, S.1339 - Pharmacy Benefit Manager Reform Act, H.R. 2679, the PBM Accountability Act, H.R.4822 - Health Care Price Transparency Act, H.R. 5378 - Lower Costs, More Transparency Act, and H.R. 4366, Consolidated Appropriations Act. Issues related to the 340B program, including H.R. 3290, to ensure transparency and oversight of the 340B drug discount program. Pandemic All-Hazards Preparedness Act (PAHPA) reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act. S.Res. 496 and S.Res.566 - National Cholesterol Education Month. S. 3558, Biosecure.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE